Pluvicto Offers Hope for Prostate Cancer Patients скачать в хорошем качестве

Pluvicto Offers Hope for Prostate Cancer Patients

Dr. Navesh Sharma, the medical director of radiation oncology at WellSpan Health, discusses an advanced treatment for prostate cancer called Pluvicto, specifically targeting prostate-specific membrane antigen (PSMA). This therapy is beneficial for patients who have progressed after other treatments like androgen receptor pathway inhibitors or chemotherapy. The treatment minimizes side effects by targeting only the cancer cells with the PSMA marker. Additionally, Dr. Sharma highlights WellSpan Health's partnership offering proton therapy, a more targeted form of radiation therapy that can be used for various cancers, reducing side effects in surrounding tissues. The multidisciplinary approach at WellSpan ensures that each patient receives the best possible treatment plan, considering options like photon and proton therapy. Keywords: Dr Navesh Sharma, WellSpan Health, radiation oncology, prostate cancer, radioimmunotherapy, Pluvicto, PSMA, prostate specific membrane antigen, androgen receptor pathway inhibitors, chemotherapy, proton therapy, multidisciplinary approach, cancer treatment options